![](https://investorshub.advfn.com/uicon/519224.png?cb=1529675851)
Wednesday, May 24, 2017 11:27:16 AM
"This technology marks a vast improvement over traditional mammography, which generally doesn’t detect the presence of cancer until it is in Stage 3 or 4. It is also much more accurate than mammography, which produces a high number of both false-positive and false-negative results. Currently, more than 70 percent of biopsies that are done as a result of a suspicious mammogram turn out to be non-cancerous tissue. And in women with dense breast tissue, mammograms miss the presence of cancer more than 50 percent of the time. Because the iTBra relies on different detection technology, its false negative rate has so far been 17.3 percent for all tissue types—an improvement for all women, but especially for those with dense tissue."
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM